Phytanic acid induces Neuro2a cell death via histone deacetylase activation and mitochondrial dysfunction

Neurotoxicology and Teratology

Volumn 48, Issue , 2015, Pages 33-39

  Nagai, Kaoru ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cell death; Histone deacetylase; Mitochondria; Phytanic acid

Indexed keywords

3 [4 [3 (3 FLUOROPHENYL) 3 OXO 1 PROPENYL] 1 METHYL 1H PYRROL 2 YL]ACRYLOHYDROXAMIC ACID; APICIDIN; BUTYRIC ACID; CASPASE 9 INHIBITOR; ENTINOSTAT; FATTY ACID; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE INHIBITOR; PHYTANIC ACID; THEOPHYLLINE; VORINOSTAT;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; DRUG CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HISTONE ACETYLATION; IN VITRO STUDY; MITOCHONDRION; MOUSE; NERVE CELL; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; REFSUM DISEASE; ANIMAL; APOPTOSIS; CELL LINE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; HISTONE DEACETYLASES; MICE; MITOCHONDRIA; NEURONS; PHYTANIC ACID;

EID: 84922032834     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2015.01.006     Document Type: Article

References (24)

1. Aburai N., Esumi Y., Koshino H., Nishizawa N., Kimura K. Inhibitory activity of linoleic acid isolated from proso and Japanese millet toward histone deacetylase. Biosci Biotechnol Biochem 2007, 71:2061-2064.
2. Allan L.A., Clarke P.R. Apoptosis and autophagy: regulation of caspase-9 by phosphorylation. FEBS J 2009, 276:6063-6073.
3. Bardai F.H., D'Mello S.R. Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3b. J Neurosci 2011, 31:1746-1751.
4. Busanello E.N.B., Amaral A.U., Tonin A.M., Zanatta A., Viegas C.M., Vargas C.R., et al. Disruption of mitochondrial homeostasis by phytanic acid in cerebellum of young rats. Cerebellum 2013, 12:362-369.
5. Carew J.S., Giles F.J., Nawrocki S.T. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. Cancer Lett 2008, 269:7-17.
6. Chaturvedi R.K., Beal M.F. Mitochondrial diseases of the brain. Free Radic Biol Med 2013, 63:1-29.
7. Chuang D.-M., Leng Y., Marinova Z., Kim H.-J., Chiu C.-T. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 2009, 32:591-601.
8. Cosio B.G., Tsaprouni L., Ito K., Jazrawi E., Adcock I.M., Barnes P.J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004, 200:689-695.
9. Cui W., Zhang Z.-J., Hu S.-H., Mak S.-H., Xu D.-P., Choi C.-L., et al. Sunitinib produces neuroprotective effect via inhibiting nitric oxide overproduction. CNS Neurosci Ther 2014, 20:244-252.
10. Ferdinandusse S., Denis S., Clayton P.T., Graham A., Rees J.E., Allen J.T., et al. Mutations in the gene encoding peroxisomal a-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 2000, 24:188-191.
11. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.-H. Recovery of learning and memory is associated with chromatin remodeling. Nature 2007, 447:178-183.
12. Fulda S. Histone deacetylase (HDAC) inhibitors and regulation of TRAIL-induced apoptosis. Exp Cell Res 2012, 318:1208-1212.
13. Guan J.-S., Haggarty S.J., Giacometti E., Dannenberg J.-H., Joseph N., Gao J., et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459:55-60.
14. Guedes-Dias P., Oliveira J.M.A. Lysine deacetylase and mitochondrial dynamics in neurodegeneration. Biochim Biopys Acta 2013, 1832:1345-1359.
15. Hellgren L.I. Phytanic acid-an overlooked bioactive fatty acid in dairy fat?. Ann NY Acad Sci 2010, 1190:42-49.
16. Koppel I., Timmusk T. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors. Neuropharmacology 2013, 75:106-115.
17. Nagai K., Chiba A., Nishino T., Kubota T., Kawagishi H. Dilinoleoyl-phosphatidylethanolamine from Hericium erinaceum protects against ER stress-dependent Neuro2a cell death via protein kinase C pathway. J Nutr Biochem 2006, 17:525-530.
18. New M., Olzscha H., La Thangue N.B. HDAC inhibitor-based therapies: can we interpret the code?. Mol Oncol 2012, 6:637-656.
19. R'nicke S., Kruska N., Kahlert S., Reiser G. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes. Neurobiol Dis 2009, 36:401-410.
20. Seidel C., Schnekenburger M., Dicato M., Diederich M. Histone deacetylase modulators provided by mother nature. Genes Nutr 2012, 7:357-367.
21. Steliou K., Boosalis M.S., Perrine S.P., Sangerman J., Faller D.V. Butyrate histone deacetylase inhibitors. Biores Open Access 2012, 1:192-198.
22. Vogelauer M., Krall A.S., McBrian M.A., Li J.-Y., Kurdistani S.K. Stimulation of histone deacetylase activity by metabolites of intermediary metabolism. J Biol Chem 2012, 287:32006-32016.
23. Wierzbicki A.S. Peroxisomal disorders affecting phytanic acid α-oxidation: a review. Biochem Soc Trans 2007, 35:881-886.
24. +. CNS Neurosci Ther 2014, 20:308-316.